T/FIF Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LLCF who wrote (796)	4/16/1999 8:51:00 AM
From: LLCF	Read Replies (1) of 1073

<You know there has been quite a bit of press in the sector lately.> Today: lead article in WSJ's "MarketPlace" section on the $43 million Big Pharma Genome project disguised as "New Era of Personalized Medicine"... once again they're badmouthing bioworld: "drug makers plan to publicly release their findings is especially valuable because it means the findings won't be exlusively controlled by small biotech companies" "One small company, Genset SA of Paris, says it has already used its preliminary gene map to identify threee genes involved in prostate cancer. But so far the company has declined to identify the genes so that other cancer researchers can begin working to understand the genes' role and develop treatments." It really is terrible the way the large pharma companies share all their drug research but biotechs won't. Guess they're just "evil"... Next, CSFB's Ales To talks with Bloomber's Jim Finkle via telephine about his new "strong buy" rating on Immunex Corp.. his recommendation of Amgen, Chiron and Genzyme... Yuk DAK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next